filmov
tv
EndoPredict Patient Video: TARA
Показать описание
EndoPredict’s accurate low-risk assessment can help breast cancer patients consider safely forgoing chemotherapy.
Myriad Genetics
Breast Cancer
Cancer
Chemotherapy
Chemo
EndoPredict
Рекомендации по теме
0:05:31
EndoPredict Patient Video: TARA
0:09:14
MammaPrint genetic testing reduces chemotherapy overtreatment in breast cancer patients
0:14:37
Genomic Testing in Breast Cancer: What You Must Know
0:04:47
Myriad Patient Education - HBOC syndrome
0:12:11
what is BRCA 1&2 test , What is Breast cancer reoccurrence test #oncotypeDx #endopredict #mamapr...
0:02:50
O Laboratório EndoPredic
0:13:41
Introduction and Walkthrough: Summary of Results for MammaPrint and BluePrint
0:00:59
Mother and Daughter Share the Benefits of BRACAnalysis® Testing
0:00:40
Nicole
0:03:09
myRisk Patient Story: Randy
0:01:16
Addition of riskScore to Myriad's myRisk Hereditary Cancer Test
0:02:02
Dra Marcia Graudenz fala um pouco mais sobre o EndoPredict
0:01:28
When to Take the Oncotype DX Breast Cancer Test
0:03:13
An Instance When the Oncotype DX Test Helped a Breast Cancer Patient
0:03:05
MammaPrint® Experiencia del Paciente
0:01:13
riskScore validation at 2017 SABCS
0:00:32
Myriad Oncology Virtual Test Ordering
0:08:50
Kim C - Myriad Patient Story - BRAC Pack Advocate
0:04:46
Conheça o Prosigna
0:01:07
New gene variants for breast cancer discovered
0:03:57
Overview of prospective phase 3 PlanB trial of 21-gene Recurrence Score® result in breast cancer
0:12:34
PD Dr. med. Cornelia Liedtke
0:09:42
Expertengespräch: Priv.-Doz. Dr. Peter Dubsky
0:10:26
ESMO 2019: 'Oncotype DX erhält als erster Genexpressionstest die Kostenerstattung.', Prof....
0:05:31
0:09:14
0:14:37
0:04:47
0:12:11
0:02:50
0:13:41
0:00:59
0:00:40
0:03:09
0:01:16
0:02:02
0:01:28
0:03:13
0:03:05
0:01:13
0:00:32
0:08:50
0:04:46
0:01:07
0:03:57
0:12:34
0:09:42
0:10:26